Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neupro for Hemispatial Neglect and Motor Deficits After Stroke
NCT00663338Phase 2Completed
- Sponsor
- University College London
- Start
- Jan 2010
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rotigotine in hemispatial neglect and motor deficit, sponsored by University College London. Primary endpoints: Hemispatial neglect and cognitive components at 38 days and Motor control at 38 days. Started Jan 2010; status: completed.
02
Drugs
rotigotine
03
Conditions
hemispatial neglectmotor deficit
Beyond the preview
Go deeper on NCT00663338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00663338.